MHRA approves Polyphor’s phase 1 trial of novel inhaled antibiotic
Murepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis
Read More
Tag: Polyphor
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
